CINGULATE INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.57 USD | -14.93% |
|
-19.72% | -92.55% |
| 05-21 | FDA Clears Cingulate to File for Marketing Approval of CTx-1301 in the Treatment of ADHD | CI |
| 05-08 | Cingulate Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
c035a98c27a.6p0twoz84H59XwK_SGpZ2aD6Iwkq6M6zSbWrnmSu4dY.nexkkrm5kikia3HyA1opv5abGmpdmJSGf4bg2QPgtL3T9Grx9ZmWKhAtYQ~41f433913303c02801c6a9d007d7523f